Predictive Signature of Benralizumab Response
Conditions: Asthma; Eosinophilic; Severe Asthma Intervention: Drug: Benralizumab Prefilled Syringe Sponsors: Nantes University Hospital; AstraZeneca; Ministère de la Santé - France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials